Clinical Trial Update: Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the bioavailability of a fixed-dose combination tablet of empagliflozin and metformin (BI 10773) compared with the monocomponents and a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• SYNJARDY (empagliflozin and metformin hydrochloride)
• metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2015-08-21